Michael Cloonan: CEO of Sionna Therapeutics
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.